Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes

Publisher： Karger

E-ISSN： 1421-9662|131|4|231-238

ISSN： 0001-5792

Source： Acta Haematologica, Vol.131, Iss.4, 2013-12, pp. : 231-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 372-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1036-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 5, 2015-09 ,pp. : 687-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Danazol Therapy for Thrombocytopenia in Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 107, Iss. 4, 2002-05 ,pp. : 234-236

Karger

Access to resources Recommend Favorite

Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 519-525

John Wiley & Sons Inc

Access to resources Recommend Favorite